L3VLUP
ProSign in

NVO in the 13F filings

Novo-nordisk A S · CUSIP 670100205

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Sep 2024
the date the book describes
Filed
5 Nov 2026
latest of these filings; the earliest 1 Nov 2024
Managers listing it
23
at least, of 95 tracked, among listed positions
Comparable managers
94
filed both Q2 2024 and Q3 2024; 18 listed it in both
Shares listed
54,927,914
combined, among listed positions
Reported value
$6.5bn
combined, at the quarter end

Among the 94 comparable managers: 12 buyers (opened or added shares) and 11 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing NVO in Q3 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2024, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

23 of 23 holders

ActionFiling
Fidelity (FMR LLC)17,931,577$2.1bn0.13%Trimmed-1,563,0655 Nov 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc9,583,435$1.1bn0.13%Added+79,67114 Nov 2024 (the filing on sec.gov)
Renaissance Technologies LLC8,189,315$975m1.47%Trimmed-976,05913 Nov 2024 (the filing on sec.gov)
Polen Capital Management LLC6,854,659$816m2.11%Trimmed-593,31310 Feb 2025 (the filing on sec.gov)
Capital World Investors4,454,016$531m0.08%Trimmed-9,86913 Nov 2024 (the filing on sec.gov)
Markel Group Inc2,150,000$256m2.30%Held01 Nov 2024 (the filing on sec.gov)
Tiger Global Management LLC1,269,000$151m0.64%Held014 Nov 2024 (the filing on sec.gov)
D. E. Shaw & Co.905,585$108m0.09%Addedn.a.14 Nov 2024 (the filing on sec.gov)
Janus Henderson Group Ltd892,427$106m0.05%Trimmed-1,17014 Nov 2024 (the filing on sec.gov)
Voloridge Investment Management LLC618,206$74m0.27%Newnew14 Nov 2024 (the filing on sec.gov)
Balyasny Asset Management LLC525,291$63m0.10%Added+141,64714 Nov 2024 (the filing on sec.gov)
Coatue Management LLC326,363$39m0.14%Added+293,46714 Nov 2024 (the filing on sec.gov)
Walleye Capital LLC251,926$30m0.06%Added+69,24114 Nov 2024 (the filing on sec.gov)
Marshall Wace LLP181,303$22munder 0.1%Trimmed-510,13814 Nov 2024 (the filing on sec.gov)
Acadian Asset Management LLC149,660$18m0.06%Trimmed-200,29412 Nov 2024 (the filing on sec.gov)
Two Sigma Advisers LP136,400$16munder 0.1%Trimmed-22,50014 Nov 2024 (the filing on sec.gov)
Artisan Partners LP122,398$15munder 0.1%Trimmed-677,77212 Nov 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP119,226$14m0.06%Added+33,22613 Nov 2024 (the filing on sec.gov)
ExodusPoint Capital Management LP115,785$14m0.08%Newnew12 Nov 2024 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC70,925$8.4m0.06%Newnew14 Nov 2024 (the filing on sec.gov)
Capital Research Global Investors54,886$6.6munder 0.1%Added+4,66913 Nov 2024 (the filing on sec.gov)
Quantbot Technologies LP25,478$3.0m0.12%Newnew13 Nov 2024 (the filing on sec.gov)
Baillie Gifford & Co53$6kunder 0.1%Added+95 Nov 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q2 2024 to Q3 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (4)

Exited (2)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
23 in Q3 2024 to 15 in Q2 2026

Tracked managers listing it, at least.

01020302014201620182020202220242026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
NVO by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20135$735mn.a.n.a.
Q3 20136$870mn.a.n.a.
Q4 20134$1.0bnn.a.n.a.
Q1 20145$1.3bnn.a.n.a.
Q2 20144$1.3bnn.a.n.a.
Q3 20144$1.3bnn.a.n.a.
Q4 20145$1.1bnn.a.n.a.
Q1 20154$1.3bnn.a.n.a.
Q2 20157$1.3bnn.a.n.a.
Q3 20156$1.3bnn.a.n.a.
Q4 20155$1.4bnn.a.n.a.
Q1 20168$1.3bnn.a.n.a.
Q2 20166$1.3bnn.a.n.a.
Q3 201614$1.2bnn.a.n.a.
Q4 201611$714mn.a.n.a.
Q1 201710$791mn.a.n.a.
Q2 20175$677mn.a.n.a.
Q3 20178$804mn.a.n.a.
Q4 20179$1.1bnn.a.n.a.
Q1 20188$1.0bnn.a.n.a.
Q2 201810$1.1bnn.a.n.a.
Q3 201810$1.2bnn.a.n.a.
Q4 201810$1.5bnn.a.n.a.
Q1 20199$1.7bnn.a.n.a.
Q2 201910$1.6bnn.a.n.a.
Q3 201910$1.8bnn.a.n.a.
Q4 201911$2.1bnn.a.n.a.
Q1 202010$2.2bnn.a.n.a.
Q2 20208$2.2bnn.a.n.a.
Q3 20207$2.2bnn.a.n.a.
Q4 20205$2.0bnn.a.n.a.
Q1 20214$1.8bnn.a.n.a.
Q2 20215$2.2bnn.a.n.a.
Q3 20217$2.4bnn.a.n.a.
Q4 20216$2.5bnn.a.n.a.
Q1 20227$2.4bnn.a.n.a.
Q2 202210$2.5bnn.a.n.a.
Q3 20227$1.8bnn.a.n.a.
Q4 202212$3.1bnn.a.n.a.
Q1 202314$3.8bnn.a.n.a.
Q2 202317$4.3bnn.a.n.a.
Q3 202320$5.6bnn.a.n.a.
Q4 202323$6.0bn148
Q1 202417$7.3bn712
Q2 202424$8.7bn157
Q3 202423$6.5bn1211
Q4 202421$4.3bn109
Q1 202518$2.8bn116
Q2 202515$2.4bn87
Q3 202515$1.6bn98
Q4 202512$1.6bn1915
Q1 202617$2.9bn2113
Q2 202615$3.0bn1318

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

NVO and LLY →NVO and JNJ →NVO and VRTX →Choose a stock to compare with NVO →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own NVO, latest filings →Back to the 13F Explorer →